Related references
Note: Only part of the references are listed.BMP4 induces HO-1 via a Smad-independent, p38MAPK-dependent pathway in pulmonary artery myocytes
Xudong Yang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor γ
Elke Burgermeister et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Peroxisome proliferator-activated receptors at the crossroads of obesity, diabetes, and cardiovascular disease
Andries J. Gilde et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Activation of peroxisome proliferator-activated receptor γ suppresses telomerase activity in vascular smooth muscle cells
D Ogawa et al.
CIRCULATION RESEARCH (2006)
PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1
K Benkirane et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Imatinib for the treatment of pulmonary arterial hypertension
HA Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Platelet-derived growth factor receptor-β (PDGFR-β) activation promotes its association with the low density lipoprotein receptor-related protein (LRP) -: Evidence for co-receptor function
CS Newton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension
SL Merklinger et al.
CIRCULATION (2005)
Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension
JT Kielstein et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo
GV Shurin et al.
JOURNAL OF IMMUNOLOGY (2005)
Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells -: Only phosphatidylinositol 3′-kinase is important
M Vantler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats
S Wakino et al.
HYPERTENSION RESEARCH (2005)
Imatinib attenuates diabetes-associated atherosclerosis
M Lassila et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease
KE Roberts et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Divergent effects of peroxisome proliferator-activated receptor γ agonists and tumor necrosis factor α on adipocyte ApoE expression
LL Yue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Genetic basis of pulmonary arterial hypertension - Current understanding and future directions
JH Newman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Peroxisome proliferator-activated receptors and atherogenesis - Regulators of gene expression in vascular cells
N Marx et al.
CIRCULATION RESEARCH (2004)
Metalloproteinase expression in PMA-stimulated THP-1 cells -: Effects of peroxisome proliferator-activated receptor-γ (PPARγ) agonists and 9-cis-retinoic acid
JR Worley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Muscle-specific Pparg deletion causes insulin resistance
AL Hevener et al.
NATURE MEDICINE (2003)
The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site
K Ishihara et al.
FEBS LETTERS (2003)
Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor γ in vascular smooth muscle cells
D Bruemmer et al.
CIRCULATION RESEARCH (2003)
Peroxisome proliferator-activated receptor gamma (PPARγ) expression is decreased in pulmonary hypertension and affects endothelial cell growth
S Ameshima et al.
CIRCULATION RESEARCH (2003)
LRP: Role in vascular wall integrity and protection from atherosclerosis
P Boucher et al.
SCIENCE (2003)
Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor γ
A Gauthier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Peroxisome proliferator-activated receptor activators inhibit oxidized low-density lipoprotein-induced endothelin-1 secretion in endothelial cells
F Martin-Nizard et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
Distinct apolipoprotein E isoform preference for inhibition of smooth muscle cell migration and proliferation
M Zeleny et al.
BIOCHEMISTRY (2002)
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives
M Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell
Y Arita et al.
CIRCULATION (2002)
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor
C Atkinson et al.
CIRCULATION (2002)
Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux
TE Akiyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Interferon-γ-mediated activation and ubiquitin-proteasome-dependent degradation of PPARγ in adipocytes
ZE Floyd et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Peroxisome proliferator-activated receptor γ ligands inhibit mitogenic induction of p21Cip1 by modulating the protein kinase Cδ pathway in vascular smooth muscle cells
S Wakino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
P27KiP1 is important in modulating pulmonary artery smooth muscle cell proliferation
BW Fouty et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Identification of a peroxisome-proliferator-activated-receptor response element in the apolipoprotein E gene control region
R Galetto et al.
BIOCHEMICAL JOURNAL (2001)
Gene expression patterns in the lungs of patients with primary pulmonary hypertension - A gene microarray analysis
MW Geraci et al.
CIRCULATION RESEARCH (2001)
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
ZM Deng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Peroxisome proliferator-activated receptor γ ligands inhibit retinoblastoma phosphorylation and G1 → S transition in vascular smooth muscle cells
S Wakino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor
KN Cowan et al.
NATURE MEDICINE (2000)
Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase
M Ishigami et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
KB Lane et al.
NATURE GENETICS (2000)
Share Paper
